Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP14 | P54578 | 3/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.36 |
| ▸ | RORC | P51449 | 8/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18204416 | 0.90 | USP14 (0.36) | USP14PTGER4RORCKDM4EATM | |
| SCHEMBL22920227 | 0.85 | KDM4E (0.48) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL22624275 | 0.83 | KDM4E (0.52) | USP14PTGER4RORCKDM4EATM | |
| SCHEMBL18220681 | 0.82 | KDM4E (0.44) | USP14PTGER4RORCKDM4EATM | |
| SCHEMBL25905707 | 0.82 | KDM4E (0.47) | USP14PTGER4RORCKDM4EATM | |
| SCHEMBL18347414 | 0.82 | KDM4E (0.47) | USP14PTGER4RORCKDM4EATM | |
| SCHEMBL17115408 | 0.81 | GPR3 (0.46) | PTGER4RORCKDM4EATML3MBTL1 | |
| SCHEMBL18030982 | 0.81 | GPR3 (0.46) | PTGER4RORCKDM4EATML3MBTL1 | |
| SCHEMBL17034459 | 0.81 | GPR3 (0.46) | PTGER4RORCKDM4EATML3MBTL1 | |
| SCHEMBL9883349 | 0.81 | KDM4E (0.55) | USP14PTGER4RORCKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210024496-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE COMPOUND | LG DISPLAY CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024496-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE COMPOUND | OCIAD1, OCIAD2, TRPA1 | USP14 4395/4885PTGER4 2949/4885RORC 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.